Who owns Selecta Biosciences?
- CUSIP Number: 816212104
Tip: Access positions for across all investors
Analyze quarterly positions in Selecta Biosciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Selecta Biosciences stock
Who bought or sold Selecta Biosciences this quarter?
There are no current stakeholders of Selecta Biosciences.
This is normal when the security:
- Has been acquired or taken private
- Has merged with another entity
- Has changed its name and has a new CUSIP (and/or symbol)
- Has been delisted and the ticker has changed
Please use Search to find the security you were looking for.
Who sold out of Selecta Biosciences?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| BlackRock | Mar 2024 | 7.3M | $4.7M |
| Vanguard Group | Mar 2024 | 6.3M | $4.1M |
| State Street Corporation | Mar 2024 | 2.1M | $1.4M |
| Goldman Sachs Group | Mar 2024 | 1.2M | $23M |
| Northern Trust | Mar 2024 | 936k | $608k |
| Nuveen Asset Management | Mar 2024 | 490k | $319k |
| Bridgeway Capital Management | Mar 2024 | 306k | $199k |
| Morgan Stanley | Mar 2024 | 221k | $144k |
| Squarepoint Ops | Mar 2024 | 109k | $71k |
| Belpointe Asset Management | Mar 2024 | 28k | $19k |
| Sphera Funds Management | Mar 2024 | 25k | $489k |
| ProShare Advisors | Mar 2024 | 21k | $13k |
| Alliancebernstein | Mar 2024 | 17k | $11k |
| Advisor Group Holdings | Mar 2024 | 7.1k | $4.6k |
| Tower Research Capital | Mar 2024 | 7.1k | $4.6k |
| MetLife Investment Advisors | Jun 2024 | 410.00 | $11k |